Observational studyEndocrinology, diabetes & metabolism2021
How good are clinicians in predicting the presence of
Observational study in Endocrinology, diabetes & metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 14 citations in OpenAlex.
- Article
- The Performance of Gram-Staining in Tailoring the Empirical Antibiotic Choice in Operated Diabetic Foot Infections.Journal of clinical medicine · 2025Article
- Antibiotic Stewardship in the Management of Infected Diabetic Foot Ulcer Disease in Less Developed Countries.Endocrinology, diabetes & metabolism · 2024Review
- Antipseudomonal Antibiotics in Diabetic Foot Infections: A Practical Perspective From a Community Hospital.Open forum infectious diseases · 2024Article
- Detection, management, and prevention of diabetes-related foot disease in the Australian context.World journal of diabetes · 2023Review
- What's old is new again: Insights into diabetic foot microbiome.World journal of diabetes · 2023Review
- Impact of a syndrome-specific antibiotic stewardship intervention on antipseudomonal antibiotic use in inpatient diabetic foot infection management.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2023Article
- Short and oral antimicrobial therapy for diabetic foot infection: a narrative review of current knowledge.Journal of bone and joint infection · 2022Review
- Personal Protective Equipment: Reply.Anesthesiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The most frequently prescribed empirical antibiotic agents for mild and moderate diabetic foot infections (DFIs) are amino-penicillins and second-generation cephalosporins that do not cover Methods: In this prospective observational study, we separately asked 13 experienced (median 11 years) healthcare workers whether they thought the Results: Among 221 DFI episodes in 88 individual patients, intraoperative tissue cultures grew Conclusion: The combined visual and olfactory performance of experienced clinicians in predicting the presence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.